Table 2.
Best-corrected visual acuity and central retinal thickness outcome at month 12.
| Characteristic | IVC group (n = 31) | Combined group (n = 30) |
|---|---|---|
| Mean BCVA letter score at month 12 ± SD | 57.9 ± 9.4 | 53.5 ± 11.8 |
| Mean CRT at month 12 ± SD, μm | 342.1 ± 76.9 | 310.8 ± 81.0 |
| Mean change in BCVA letter score from baseline to month 12 | ||
| Mean ± SD | 9.1 ± 4.5 | 7.5 ± 4.2 |
| P value | 0.164∗ | |
| Mean CRT change from baseline to month 12 ± SD, μm | ||
| Mean ± SD | −145.1 ± 69.9 | −168.5 ± 53.6 |
| P value | 0.149∗ | |
| Categorized BCVA letter score outcome at month 12, n (%) | ||
| Gain of ≥5 | 25 (80.6) | 22 (73.3) |
| Gain of ≥10 | 14 (45.2) | 10 (33.3) |
| Gain of ≥15 | 4 (12.9) | 2 (6.7) |
IVC: intravitreal conbercept; BCVA: best-corrected visual acuity; CRT: central retinal thickness; SD: standard deviation.
∗Independent t-test.